Patent classifications
C07D487/22
SUPRAMOLECULAR PHOTOPROTECTION OF A PHOTOSENSITIZER
Disclosed herein are compositions comprising a water-soluble host-guest complex formed from a host receptor and a guest photosensitizer for the photoprotection of the photosensitizer. Also disclosed are methods of using the composition for generating reactive oxygen species, inhibiting the proliferation or killing of a cell, treating a subject with a cell proliferative disease or disorder.
PROTOPORPHYRIN IX DERIVATIVES AND USE THEREOF TO IMPROVE THE HEALTH OF PLANTS
Provided herein are compounds of general Formula I:
##STR00001##
or agriculturally acceptable salts thereof. The compounds of Formula I can be used to improve the health of plants. For example, the compounds of Formula I can be used to inhibit a microbial pathogen of a plant, or to increase resistance of a plant to one or more abiotic stress.
PIM kinase inhibitor compositions, methods, and uses thereof
This application relates to compounds of formulae (I) and (II) and compositions thereof useful as inhibitors of PIM kinases. Also provided are methods of synthesis and methods of use of PIM inhibitors in treating individuals suffering from cancerous malignancies.
PIM kinase inhibitor compositions, methods, and uses thereof
This application relates to compounds of formulae (I) and (II) and compositions thereof useful as inhibitors of PIM kinases. Also provided are methods of synthesis and methods of use of PIM inhibitors in treating individuals suffering from cancerous malignancies.
Porous materials
Porous materials (such as organic polyamine cage compounds) and methods of stabilising porous materials which are otherwise prone to pore-collapse are described. Such stabilisation is accomplished through the use of molecular ties to create bridges between reactive groups of a (potentially) porous material to thereby strengthen and stabilise the porous structure. The chemistry involved in, and the results of, the stabilisation of porous materials to provide a new sorption composition comprising the very materials which are generally prone to pore-collapse are also described.
Porous materials
Porous materials (such as organic polyamine cage compounds) and methods of stabilising porous materials which are otherwise prone to pore-collapse are described. Such stabilisation is accomplished through the use of molecular ties to create bridges between reactive groups of a (potentially) porous material to thereby strengthen and stabilise the porous structure. The chemistry involved in, and the results of, the stabilisation of porous materials to provide a new sorption composition comprising the very materials which are generally prone to pore-collapse are also described.
Hsp90 inhibitors and uses thereof
Herein is described the design and synthesis of resorcylate aminopyrazole compounds. These compounds show broad, potent and fungal-selective Hsp90 inhibitory activity. These compounds also find use in treating Hsp90 related diseases.
Hsp90 inhibitors and uses thereof
Herein is described the design and synthesis of resorcylate aminopyrazole compounds. These compounds show broad, potent and fungal-selective Hsp90 inhibitory activity. These compounds also find use in treating Hsp90 related diseases.
TETRACYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF
Disclosed is a tetracyclic pyrimidinone compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The compound having a structure represented by formula (I) is a new Lp-PLA2 inhibitor usable for treatment of neurodegenerative-related diseases, such as Alzheimer's disease (AD), glaucoma and age-related macular degeneration (AMD), or of cardiovascular diseases including atherosclerosis.
##STR00001##
TETRACYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF
Disclosed is a tetracyclic pyrimidinone compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The compound having a structure represented by formula (I) is a new Lp-PLA2 inhibitor usable for treatment of neurodegenerative-related diseases, such as Alzheimer's disease (AD), glaucoma and age-related macular degeneration (AMD), or of cardiovascular diseases including atherosclerosis.
##STR00001##